CRBU
Price
$1.86
Change
+$0.10 (+5.68%)
Updated
Dec 3 closing price
Capitalization
173.85M
102 days until earnings call
Intraday BUY SELL Signals
GLSI
Price
$8.41
Change
+$0.41 (+5.12%)
Updated
Dec 3 closing price
Capitalization
116.52M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs GLSI

Header iconCRBU vs GLSI Comparison
Open Charts CRBU vs GLSIBanner chart's image
Caribou Biosciences
Price$1.86
Change+$0.10 (+5.68%)
Volume$808.23K
Capitalization173.85M
Greenwich LifeSciences
Price$8.41
Change+$0.41 (+5.12%)
Volume$81.89K
Capitalization116.52M
CRBU vs GLSI Comparison Chart in %
CRBU
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBU vs. GLSI commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and GLSI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CRBU: $1.76 vs. GLSI: $8.00)
Brand notoriety: CRBU and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 21% vs. GLSI: 37%
Market capitalization -- CRBU: $173.85M vs. GLSI: $116.52M
CRBU [@Biotechnology] is valued at $173.85M. GLSI’s [@Biotechnology] market capitalization is $116.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 4 bearish.
  • GLSI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CRBU and GLSI are a good buy in the short-term.

Price Growth

CRBU (@Biotechnology) experienced а -5.88% price change this week, while GLSI (@Biotechnology) price change was -4.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

GLSI is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($174M) has a higher market cap than GLSI($117M). CRBU YTD gains are higher at: 10.692 vs. GLSI (-28.762). GLSI has higher annual earnings (EBITDA): -18.14M vs. CRBU (-150.76M). CRBU has more cash in the bank: 184M vs. GLSI (3.13M). CRBU has higher revenues than GLSI: CRBU (9.12M) vs GLSI (0).
CRBUGLSICRBU / GLSI
Capitalization174M117M149%
EBITDA-150.76M-18.14M831%
Gain YTD10.692-28.762-37%
P/E RatioN/AN/A-
Revenue9.12M0-
Total Cash184M3.13M5,888%
Total Debt25.9MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CRBUGLSI
RSI
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
84%
Momentum
ODDS (%)
Bearish Trend 7 days ago
87%
Bullish Trend 7 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 7 days ago
89%
Aroon
ODDS (%)
Bullish Trend 7 days ago
80%
Bearish Trend 7 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHEXY13.85N/A
N/A
Adecco Group AG
HOCFF346.39N/A
N/A
Hochtief AG
ODDAF0.05N/A
N/A
Odd Burger Corporation
MSHHF48.34N/A
N/A
MENSCH UND MASCHINE SOFTWARE SE
IQEPY1.75N/A
N/A
IQE Plc

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-0.56%
CRSP - CRBU
59%
Loosely correlated
-1.13%
RXRX - CRBU
53%
Loosely correlated
-0.69%
BEAM - CRBU
52%
Loosely correlated
-2.83%
MGNX - CRBU
51%
Loosely correlated
-2.06%
AXON - CRBU
50%
Loosely correlated
+0.91%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with CRSP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-2.91%
CRSP - GLSI
41%
Loosely correlated
-1.13%
MRNA - GLSI
38%
Loosely correlated
-0.41%
CELC - GLSI
37%
Loosely correlated
-1.01%
CRBU - GLSI
37%
Loosely correlated
-0.56%
RXRX - GLSI
37%
Loosely correlated
-0.69%
More